Oncology & Cancer

FDA authorizes marketing of EndoRotor system

The U.S. Food and Drug Administration granted marketing authorization to the EndoRotor System, which provides a minimally invasive way to resect and remove necrotic tissue for patients with walled-off pancreatic necrosis ...

Diseases, Conditions, Syndromes

Team finds convalescent plasma safe for diverse patients with COVID-19

Mayo Clinic researchers and collaborators have found investigational convalescent plasma to be safe following transfusion in a diverse group of 20,000 patients. The findings—from the U.S. Food and Drug Administration's ...

page 2 from 7